Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:926-934

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jugdutt, B. I.
Right arrow Articles by Blinston, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jugdutt, B. I.
Right arrow Articles by Blinston, G. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Hazardous Substances DB
*ISOSORBIDE DINITRATE

(Circulation. 1995;92:926-934.)
© 1995 American Heart Association, Inc.


Articles

Impact of Left Ventricular Unloading After Late Reperfusion of Canine Anterior Myocardial Infarction on Remodeling and Function Using Isosorbide-5-Mononitrate

Bodh I. Jugdutt, MD, MSc, FRCPC; Mohammad I. Khan, MBBS; S. Joanne Jugdutt, BA; Gordon E. Blinston, PhD

From the Cardiology Division of the Department of Medicine, University of Alberta, Edmonton, Canada.

Background Late reperfusion during acute myocardial infarction results in delayed recovery of ventricular function and less remodeling, whereas ventricular unloading with nitrates improves function and attenuates remodeling. Whether late reperfusion combined with prolonged unloading with isosorbide-5-mononitrate (ISMN) might produce greater functional recovery and less remodeling than late reperfusion alone is not known.

Methods and Results In vivo left ventricular function and topography (echocardiograms), postmortem topography (planimetry), and collagen (hydroxyproline) were measured in dogs that were randomized to reperfusion 2 hours after left anterior descending coronary artery ligation, and ISMN (n=12) or placebo (n=12) was given as 25 mg IV over 4 hours followed by 50 mg PO QID for 6 weeks. Compared with placebo, the ISMN group had similar heart rate but lower left atrial pressure, mean arterial pressure, and rate-pressure products. Although in vivo baseline remodeling and functional parameters were similar in the two groups, by 6 weeks the ISMN group had smaller (P<=.05) infarct and noninfarct segment lengths, ventricular volumes, and mass; less (P<.001) asynergy; and greater (P<.001) ejection fraction. More important, by 2 days, ejection fraction was 18% greater (P<.025) and asynergy 26% less (P<.05) with ISMN. At 6 weeks, ISMN showed less (P<=.05) scar size, scar collagen, cavity dilation, noninfarct wall thickness, and apical bulging than placebo. In another 4 dogs, acute ISMN produced less improvement in function and remodeling than prolonged ISMN.

Conclusions Late reperfusion of acute anterior myocardial infarction combined with prolonged ISMN unloading results in greater and earlier recovery of ventricular function and less remodeling than late reperfusion alone.


Key Words: remodeling • reperfusion • hypertrophy • proteins




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Ertl and S. Frantz
Healing after myocardial infarction
Cardiovasc Res, April 1, 2005; 66(1): 22 - 32.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Ertl and S. Frantz
Wound model of myocardial infarction
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H981 - H983.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. I. Jugdutt and V. Menon
Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 217 - 226.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
B. Meyns, J. Stolinski, V. Leunens, E. Verbeken, and W. Flameng
Left ventricular support by Catheter-Mountedaxial flow pump reduces infarct size
J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1087 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. I. Jugdutt and V. Menon
Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 95 - 107.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
B. I. Jugdutt
Monocytosis and adverse left ventricular remodeling after reperfused myocardial infarction
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 247 - 250.
[Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
B. I Jugdutt and M. Balghith
Enhanced regional AT2-receptor and PKC{varepsilon} expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 134 - 140.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Yi Xu, V. Menon, and B. I Jugdutt
Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-{varepsilon} in acutely reperfused myocardial infarction in the dog: Effect of UP269-6 and losartan on AT1- and AT2-receptor expression and IP3 receptor and PKC{varepsilon} proteins
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 184 - 195.
[Abstract] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. I. Jugdutt, Yi Xu, M. Balghith, R. Moudgil, and V. Menon
Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKC{varepsilon} Proteins and cGMP
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 301 - 311.
[Abstract] [PDF]


Home page
CirculationHome page
U. Elkayam, J. V. Johnson, A. Shotan, S. Bokhari, A. Solodky, M. Canetti, O. R. Wani, and I. S. Karaalp
Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition
Circulation, May 25, 1999; 99(20): 2652 - 2657.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. J. Mahmarian, L. A. Moye, D. A. Chinoy, R. F. Sequeira, G. B. Habib, W. J. Henry, A. Jain, B. R. Chaitman, C. S. W. Weng, H. Morales-Ballejo, et al.
Transdermal Nitroglycerin Patch Therapy Improves Left Ventricular Function and Prevents Remodeling After Acute Myocardial Infarction : Results of a Multicenter Prospective Randomized, Double-Blind, Placebo-Controlled Trial
Circulation, May 26, 1998; 97(20): 2017 - 2024.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. McDonald, C. Chu, G. Francis, D. Judd, W. Carlyle, C. Toher, K. Hauer, and M. Hartman
The effect of delayed reperfusion following infarction in the rat on structural changes in viable myocardium
Cardiovasc Res, December 1, 1997; 36(3): 347 - 353.
[Abstract] [Full Text] [PDF]